Selection of the optimal dose for an ultra-short course subcutaneous immunotherapy (SCIT) for Rhinoconjunctivitis for Birch Allergic patients

被引：0

作者：

Worm, Margitta ^{[1
]}

Zielen, Stefan ^{[2
]}

Higenbottam, Tim ^{[3
]}

Pfaar, Oliver ^{[4
]}

Mosges, Ralph ^{[5
]}

Aberer, Werner ^{[6
]}

Kramer, Matthias ^{[7
]}

Skinner, Murray ^{[3
]}

Lees, Bev ^{[3
]}

机构：

[1] Charite Univ Med Berlin, Berlin, Germany

[2] Goethe Univ Frankfurt Main, Klinikum Frankfurt 2Univ, Frankfurt, Germany

[3] Allergy Therapeut, Worthing, England

[4] Univ Med Mannheim, Dept Otorhinolaryngol Head & Neck Surg, Mannheim, Germany

[5] Univ Cologne, Cologne, Germany

[6] Med Univ Graz, Dept Dermatol & Venerol, Graz, Austria

[7] Bencard GmbH, Munich, Germany

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2016.12.491

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

478

引用

页码：AB150 / AB150

页数：1

共 50 条

[31] Clinical and immunological correlates of pre-co-seasonal sublingual immunotherapy with birch monomeric allergoid in patients with allergic rhinoconjunctivitis
Burastero, S.
Falagiani, P.
Paolucci, C.
Breda, D.
Roncarolo, D.
Zanotta, S.
Mistrello, G.
ALLERGY, 2008, 63 : 227 - 227
[32] CLINICAL AND IMMUNOLOGICAL CORRELATES OF PRE-CO-SEASONAL SUBLINGUAL IMMUNOTHERAPY WITH BIRCH MONOMERIC ALLERGOID IN PATIENTS WITH ALLERGIC RHINOCONJUNCTIVITIS
Burastero, S. E.
Mistrello, G.
Paolucci, C.
Breda, D.
Roncarolo, D.
Zanotta, S.
Falagiani, P.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (02) : 343 - 352
[33] Subcutaneous Allergen Immunotherapy (SCIT) and Its Effects on Irritability and Sleep in Patients with Allergic Rhinitis (AR) Utilizing a Structured Questionnaire
Reed, Jewmaull
Talamo, Maria
Tobin, Mary C.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB216 - AB216
[34] Quality of life improvement in patients with grass pollen-related rhinoconjunctivitis and asthma after ultra short course specific immunotherapy (uSCIT)
Rabe, U.
Hanfland, J.
Fiedler, G.
ALLERGY, 2008, 63 : 493 - 493
[35] Timing of changes in quality of life scores and rhinoconjunctivitis symptom scores in patients with perennial allergic rhinoconjunctivitis in the course of six months sublingual immunotherapy
Christoff, G. C.
Karova, E. G.
ALLERGY, 2015, 70 : 373 - 373
[36] Improvement in quality of life for patients with tree pollen-related rhinoconjunctivitis and asthma after ultra short course specific immunotherapy (uSCIT)
Rabe, U.
Hanfland, J.
Fiedler, G.
ALLERGY, 2008, 63 : 493 - 493
[37] Safety of an accelerated dose escalation scheme for an one strength subcutaneous allergen immunotherapy preparation in patients with allergic rhinoconjunctivitis triggered by house dust mite allergens
Kosowska, A.
Zemelka-Wiacek, M.
Popowicz, E.
Zajac, J.
Jutel, M.
ALLERGY, 2021, 76 : 53 - 53
[38] Real-life safety experience of ultra short course subcutaneous immunotherapy with Pollinex Quattro
von Weikersthal-Drachengberg, F. K.
Geisler, A.
ALLERGY, 2008, 63 : 251 - 251
[39] Clinical evaluation of subcutaneous immunotherapy with a polymerized molecular allergoid of Alt a 1 in patients with allergic rhinoconjunctivitis and/or allergic asthma caused by the mould Alternaria alternata
Torres, Angel Ferrer
EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 55 (06) : 303 - 309
[40] Study of impact of subcutaneous pre-seasonal tree and/or grass pollen immunotherapy (with MPL adjuvant) on patients with allergic rhinoconjunctivitis
Azmi, S.
Tsoumani, M.
Liau, J. L.
Addison, J.
Burrows, H.
Chew, F.
Marinho, S.
ALLERGY, 2019, 74 : 334 - 335

← 1 2 3 4 5 →